Chemical Compound
Pimavanserin tartrate
CAS Registry Number
706782-28-7
Primary Record
Pimavanserin tartrate
- In stock
- 9,941 g
- Purity
- 98.5 %
- CAS
- 706782-28-7
Compound Identifiers & Properties
- CAS
- 706782-28-7
- PubChem CID
- 11672491
- SMILES
- CC(C)COC1=CC=C(C=C1)CNC(=O)N(CC2=CC=C(C=C2)F)C3CCN(CC3)C.CC(C)COC1=CC=C(C=C1)CNC(=O)N(CC2=CC=C(C=C2)F)C3CCN(CC3)C.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O
- Canonical SMILES
- CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1.CC(C)COc1ccc(CNC(=O)N(Cc2ccc(F)cc2)C2CCN(C)CC2)cc1.O=C(O)[C@H](O)[C@@H](O)C(=O)O
Names & Synonyms
- Pimavanserin tartrate
- Nuplazid
- UNII-NA83F1SJSR
- Pimavanserin
- 706782-28-7
- pimavanserin hemitartrate
- Nuplazide (TN)
- NA83F1SJSR
- Pimavanserin tartrate?
- ACP-103
- ACP-103 hemitartrate
- Pimavanserin tartrate [USAN]
- RefChem:59075
- Pimavanserin tartaric acid
- ACP 103
- PimavanserintartrateorACP103
- 706782-28-7 (tartrate)
- Pimavanserin tartrate (USAN)
- CHEBI:133014
- DTXSID50220958
- Pimavanserin Impurity reference
- orb1300322
- SCHEMBL29384707
- DTXCID80143449
- MFCD09970919
- Pimavanserin Dihydroxysuccinate(2:1)
- RGSULKHNAKTFIZ-CEAXSRTFSA-N
- HMS3886L06
- PIMAVANSERIN TARTRATE [MI]
- C54H74F2N6O10
- s8183
- AKOS027327334
- PIMAVANSERIN TARTRATE [WHO-DD]
- ACN-037476
- CCG-270608
- EBC-108072
- CID11672491
- AC-29901
- AS-56699
- BP164269
- FP104271
- Pimavanserin tartrate - Bio-X trade mark
- SC-90507
- PIMAVANSERIN TARTRATE [ORANGE BOOK]
- LS-193533
- FT-0701299
- Pimavanserin tartrate, 99% - 250MG 250mg
- D08969
- A901390
- Q27284759
- (2R,3R)-2,3-dihydroxybutanedioic acid;1-[(4-fluorophenyl)methyl]-1-(1-methylpiperidin-4-yl)-3-[[4-(2-methylpropoxy)phenyl]methyl]urea
- Bis(1-(4-Fluorobenzyl)-1-(1-methylpiperidin-4-yl)-3-(4-(2-methylpropoxy)benzyl)urea) (2R,3R)-2,3-dihydroxybutanedioate
- N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R,3R)-dihydroxybutanedioate (2:1)
- Urea, N-((4-fluorophenyl)methyl)-N-(1-methyl-4-piperidinyl)-N'-((4-(2-methylpropoxy)phenyl)methyl)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1)
- 1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)-1-(1-methylpiperidin-4-yl)urea (2R,3R)-2,3-dihydroxysuccinate
- 1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)-1-(1-methylpiperidin-4-yl)urea, ((2R,3R)-2,3-dihydroxysuccinate) (2:1)
- (2R,3R)-2,3-Dihydroxybutanedioic acid--N-[(4-fluorophenyl)methyl]-N-(1-methylpiperidin-4-yl)-N'-{[4-(2-methylpropoxy)phenyl]methyl}urea (1/2)
- (2R,3R)-2,3-dihydroxybutanedioic acid; bis(1-[(4-fluorophenyl)methyl]-1-(1-methylpiperidin-4-yl)-3-{[4-(2-methylpropoxy)phenyl]methyl}urea)
- (2R,3R)-2,3-dihydroxybutanedioic acid;1-[(4-fluorophenyl)methyl]-3-[(4-isobutoxyphenyl)methyl]-1-(1-methyl-4-piperidyl)urea
- 1-(4-fluorobenzyl)-3-(4-isobutoxybenzyl)-1-(1-methylpiperidin-4-yl)urea hemi((2R,3R)-2,3-dihydroxysuccinate)
- bis(4-{[(4-fluorophenyl)methyl]({[4-(2-methylpropoxy)phenyl]methyl}carbamoyl)amino}-1-methylpiperidin-1-ium) (2R,3R)-2,3-dihydroxybutanedioate
- Bis[1-(4-fluorobenzyl)-1-(1-methylpiperidin-4-yl)-3-[4-(2-methylpropoxy)benzyl]urea] (2R,3R)-2,3-dihydroxybutanedioate
- bis{N-[(4-fluorophenyl)methyl]-N-(1-methylpiperidin-4-yl)-N'-{[4-(2-methylpropoxy)phenyl]methyl}urea} (2R,3R)-2,3-dihydroxybutanedioate
- N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide